Satavaptan fumarate is a selective non-peptide vasopressin V2 receptor antagonist. References: Bishara B, Shiekh H, Karram T, Rubinstein I, Azzam ZS, Abu-Saleh N, Nitecki S, Winaver J, Hoffman A, Abassi ZA. Effects of novel vasopressin receptor antagonists on renal function and cardiac hypertrophy in rats with experimental congestive heart failure. J Pharmacol Exp Ther. 2008 Aug;326(2):414-22. doi: 10.1124/jpet.108.137745. Epub 2008 May 8. PubMed PMID: 18467593.

纯度：≥98%

CAS：185913-79-5